Janey L. Wiggs, MD, PhD

Janey L. Wiggs, MD, PhD Selected to Receive 2022 Weisenfeld Award

September 8, 2020

Headshot of Dr. Janey WiggsFaculty member Janey L. Wiggs, MD, PhD, has been selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive the 2022 Mildred Weisenfeld Award for Excellence in Ophthalmology in recognition of her distinguished scholarly contributions to the clinical practice of ophthalmology. This award was established as a tribute to Ms. Weisenfeld's outstanding contributions to the field, which include the founding of Fight for Sight in 1946.... Read more about Janey L. Wiggs, MD, PhD Selected to Receive 2022 Weisenfeld Award

Janey L. Wiggs, MD, PhD, Elected to the National Academy of Medicine

October 16, 2018

Janey Wiggs, MD, PhDJaney L. Wiggs, MD, PhD, the Paul A. Chandler Professor of Ophthalmology and Associate Director of the Ocular Genomics Institute at Harvard Medical School, and the Associate Chief for Clinical Research in Ophthalmology and Interim Glaucoma Service Director at Massachusetts Eye and Ear, has been elected to the prestigious National Academy of Medicine (NAM).

... Read more about Janey L. Wiggs, MD, PhD, Elected to the National Academy of Medicine

Janey Wiggs headshot

Janey L. Wiggs, MD, PhD, receives ARVO Dr. David L. Epstein Award

January 30, 2018

Janey L. Wiggs, MD, PhD, Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School, Associate Chief of Ophthalmology Clinical Research and Associate Director of the Howe Laboratory at Massachusetts Eye and Ear, is the 2018 recipient of the Dr. David L. Epstein Award, an honor given by the Association for Research in Vision and Ophthalmology (ARVO). Dr. Wiggs will receive the...

Read more about Janey L. Wiggs, MD, PhD, receives ARVO Dr. David L. Epstein Award
Janey Wiggs

Joint effort targets genes and traits to improve glaucoma screening, prevention and treatment

September 29, 2016

NIH and India fund collaborative grant for glaucoma research

Boston, Mass. —  Researchers from the U.S. and India have begun a new collaborative project to identify genetic risk factors and traits related to glaucoma, a leading cause of blindness worldwide. Funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), and India’s Department of Biotechnology (DBT), the researchers’ goal is to help develop effective screening, prevention, and treatment strategies for glaucoma. Grants from the two agencies...

Read more about Joint effort targets genes and traits to improve glaucoma screening, prevention and treatment
Panel-based Genetic Diagnostic Testing for Eye Disease

Panel-based Genetic Diagnostic Testing for Eye Disease

December 1, 2014

Researchers Report that Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases is Highly Accurate and More Sensitive than Exome Sequencing
Findings published online in Genetics in Medicine

Contact: Mary Leach 

BOSTON, MASS. (Nov. 20, 2014) --Investigators at Massachusetts Eye and Ear and Harvard Medical School Department of Ophthalmology and colleagues reported the development and characterization of a...

Read more about Panel-based Genetic Diagnostic Testing for Eye Disease